Unilateral spinal anesthesia (USpA) has been reported to potentiate spinal anaesthesia and is used in geriatric patients. The purpose of this study was to determine the median effective dose (ED50) of 0.5% hypobaric bupivacaine and 0.5% hypobaric ropivacaine USpA for geriatric patients (age ≥ 70 years) undergoing elective hip replacement surgery.
Methods
A total of 60 geriatric patients (age ≥ 70 years) undergoing elective hip replacement surgery were enrolled in this study. The patients were randomized into 2 groups to receive either intrathecal 0.5% hypobaric bupivacaine USpA (group B) or 0.5% hypobaric ropivacaine USpA (group R). Effective anesthesia was defined as a T10 sensory blockade level maintained for more than 60 min, and a Bromage score of 3 on the operation side within 10 min after injection with no additional epidural anesthetic required during surgery. The ED50 of 0.5% hypobaric bupivacaine and 0.5% hypobaric ropivacaine was calculated using the Dixon and Massey formula.
Results
No significant differences were found between the two groups in terms of demographic data. The ED50 of 0.5% hypobaric bupivacaine USpA was 4.66 mg (95% confidence interval CI 4.69–4.63 mg) mg and that of 0.5% hypobaric ropivacaine USpA was 6.43 mg (95% CI 6.47–6.39 mg) for geriatric patients undergoing hip replacement surgery.
Conclusion
We find the ED50 were lower, and the ED50 of 0.5% hypobaric bupivacaine and ropivacaine was 4.66 mg (95% CI 4.69–4.63 mg) and 6.43 mg (95% CI 6.47–6.39 mg), respectively, for USpA in geriatric patients (age ≥ 70 years) undergoing elective hip replacement surgery.
European Journal of Orthopaedic Surgery & Traumatology - Closed reduction and spica cast is still the preferred treatment option for children presenting with developmental dysplasia of the hip... 相似文献
PurposeThe purpose of this study was to identify the correlation between the vascular development of the femoral head and avascular necrosis (AVN) in patients with developmental dysplasia of the hip (DDH) treated by closed reduction (CR).MethodsWe retrospectively reviewed 78 patients with DDH treated by CR (83 hips). The vascular maturity, number of vessels and perfusion changes of the femoral head were assessed on perfusion MRI (pMRI) before and after CR.ResultsThe number of vessels (mean 4.2 sd 1.4) of the femoral head and the ratio (36.1%) of mature vessels (type III) on the dislocated side were significantly less than those at contralateral side (mean 6.0 sd 1.2; 82.2%) (p < 0.001). Of the included 83 hips, 39 hips (61.5%) showed decreased perfusion of the femoral head, including partial decreased (Class B, 47.0%) and global decreased (Class C, 14.5%), at the dislocated side, which was significantly more than those at contralateral side (0.0%) (p < 0.001). In total, 32 out of 83 hips (38.5%) developed AVN. The rate of AVN with Class A (18.8%) which perfusion of the femoral head was normal (unchanged or enhanced) was significantly less than those with Class C (66.7%) (p = 0.006).ConclusionThe vascular development and perfusion changes of the femoral head on the dislocated side are significantly worse than those at contralateral side. Immature vascularity of the femoral head before CR and poor perfusion of the femoral head after CR may be risk factors for AVN in patients with DDH.Level of evidenceIII 相似文献
Ezrin, a membrane organizer and linker between plasma membrane and cytoskeleton, is well documented to play an important role
in the metastatic capacity of cancer cells especially for osteosarcoma cells. It has provided an ideal target for cancer gene
therapy. RNA-cleaving 10–23 DNAzymes, consisting of a 15-nucleotide catalytical domain flanked by two target-specific complementary
arms, can cleave the target mRNA at purine–pyrimidine dinucleotide effectively. In the present study, we designed and screened
the target sites for 10–23 DNAzymes against ezrin mRNA by using multiple computational methods with combination of secondary
structural and hybridization thermodynamic parameters. Then, we testified the activities of the DNAzymes directed against
these selected target sites in vitro. Our results show that AU1751 is the most effective target site of ezrin mRNA for DNAzymes
because of its ideal secondary structure and hybridization thermodynamics. So, there is a significant correlation between
the multiple computational methods and the efficacy of the corresponding DNAzymes. These provide a rational, efficient way
for DNAzymes selection. 相似文献